| __timestamp | Galapagos NV | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 31354781 |
| Thursday, January 1, 2015 | 129714000 | 43445817 |
| Friday, January 1, 2016 | 139574000 | 66489820 |
| Sunday, January 1, 2017 | 218502000 | 96886134 |
| Monday, January 1, 2018 | 322876000 | 153793000 |
| Tuesday, January 1, 2019 | 427320000 | 148369000 |
| Wednesday, January 1, 2020 | 523667000 | 151934000 |
| Friday, January 1, 2021 | 491707000 | 198532000 |
| Saturday, January 1, 2022 | 515083000 | 112128000 |
| Sunday, January 1, 2023 | 241294000 | 76192000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Galapagos NV and TG Therapeutics, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D). From 2014 to 2023, Galapagos NV consistently outpaced TG Therapeutics, Inc. in R&D spending, with an average annual investment nearly three times higher. Notably, in 2020, Galapagos NV peaked with a 523% increase from its 2014 spending, while TG Therapeutics, Inc. saw a 484% rise in the same period. However, 2023 marked a significant drop for both companies, with Galapagos NV reducing its R&D expenses by over 50% from its 2020 high. This trend highlights the dynamic nature of biotech investments and the strategic shifts companies make in response to market conditions and scientific breakthroughs.
Comparing Innovation Spending: Eli Lilly and Company and Galapagos NV
Research and Development Investment: Sanofi vs Galapagos NV
Summit Therapeutics Inc. vs Galapagos NV: Strategic Focus on R&D Spending
Exelixis, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
Comparing Innovation Spending: Madrigal Pharmaceuticals, Inc. and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and Perrigo Company plc
Research and Development Investment: TG Therapeutics, Inc. vs Soleno Therapeutics, Inc.
TG Therapeutics, Inc. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Galapagos NV
Analyzing R&D Budgets: Veracyte, Inc. vs Galapagos NV
Wave Life Sciences Ltd. or Galapagos NV: Who Invests More in Innovation?